Parameter
| Biomarker | NBL1 | Full name | Neuroblastoma oncogenic inhibitory factor 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Evaluation of renal interstitial fibrosis and prediction of disease progression |
| Disease | Glomerulonephritis (GN) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Serum | ||
| Pathobiological Mechanisms | It was significantly correlated with the severity of renal interstitial fibrosis and the progression of renal disease in IgAN patients, reflecting the degree of renal fibrosis. | ||||
| Clinical Availability Status | Research verification stage：Evaluating the risk of fibrosis requires clinical application verification. | ||||
| Notes and Dynamics | Noninvasive monitoring of the progression of IgAN renal interstitial fibrosis can guide the timing of anti-fibrosis treatment. | ||||